Diffuse Large B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Diffuse Large B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-09-10Clinical Trial Update: Lenalidomide Plus R-CHOP for CNS Relapse Prophylaxis in Diffuse Large B-cell Lymphoma [Phase 2]
Phase 2 trial evaluating lenalidomide plus R-CHOP as prophylaxis for CNS relapse in diffuse large B-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2020-09-01Clinical Trial Update: To Decrease Fatigue With Light Therapy [Phase 3]
Phase 3 trial investigating light therapy to decrease fatigue in patients with Hodgkin lymphoma and diffuse large B-cell lymphoma has comple…
-
CLINICAL_TRIALS trial_result · 2020-08-13Clinical Trial Update: A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Rituximab (MabThera/Rituxan) in Participants With Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL) [Phase 3]
Phase 3 study evaluating safety, efficacy, and pharmacokinetics of Rituximab in diffuse large B-cell lymphoma and follicular lymphoma has co…
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: A Study Comparing the Efficacy and Safety Between I-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients [Phase 3]
Phase 3 trial comparing I-CHOP versus R-CHOP in untreated CD20-positive diffuse large B-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas. [Phase 2]
Phase 2 trial update for an oral LY317615 in relapsed or refractory diffuse large B-cell lymphoma, with completed status and results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-06Clinical Trial Update: Chemotherapy for Participants With Lymphoma [Phase 2]
Phase 2 trial update on chemotherapy for participants with diffuse large B-cell lymphoma (DLBCL) shows completed status; results posted in 2…
-
CLINICAL_TRIALS trial_result · 2020-08-05Clinical Trial Update: YY-20394 、GEMOX Treatment Diffuse Large B-cell Lymphoma Single Arm, Open, Multicentrized Phase 1b/2 Clinical Trial [Phase 1, Phase 2]
A multicenter open-label Phase 1b/2 trial evaluating YY-20394 in combination with GEMOX for diffuse large B-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Evaluate a Treatment Adapted to the PET Response Compared to a Standard Treatment, for Low Risk DLBCL CD 20+ Patients [Phase 3]
Phase 3 trial evaluating a PET response-adapted treatment versus standard treatment in low-risk CD20+ diffuse large B-cell lymphoma (DLBCL).
-
CLINICAL_TRIALS trial_result · 2020-06-26Clinical Trial Update: Study of Safety and Efficacy of KTE-C19 in Combination With Atezolizumab in Adults With Refractory Diffuse Large B-Cell Lymphoma (DLBCL) [Phase 1, Phase 2]
A Phase 1/2 trial evaluating KTE-C19 in combination with atezolizumab in adults with refractory diffuse large B-cell lymphoma has completed …
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Toripalimab Combine With Rituximab for Treatment of Relapsed Refractory CD20 Positive Diffuse Large B-cell Lymphoma [Phase 2]
Phase 2 clinical trial update evaluating toripalimab in combination with rituximab for relapsed/refractory CD20-positive diffuse large B-cel…
-
CLINICAL_TRIALS trial_result · 2020-06-02Clinical Trial Update: Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies [Phase 2]
Phase 2 trial of Entospletinib plus Idelalisib in adults with relapsed or refractory hematologic malignancies was terminated; results posted…
-
CLINICAL_TRIALS trial_result · 2020-06-02Clinical Trial Update: Reduced Radiation in Patients With Diffuse Large B-cell Lymphoma [NA]
Clinical trial update reporting results of reduced radiation in patients with diffuse large B-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Pembrolizumab in Patients Failing to Respond to or Relapsing After CAR T Cell Therapy for Relapsed or Refractory Lymphomas [Phase 1, Phase 2]
Phase 1/2 trial evaluating pembrolizumab in patients with diffuse large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma who f…
-
CLINICAL_TRIALS trial_result · 2020-05-07Clinical Trial Update: Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 safety and tolerability study of PCI-32765 in various B-cell malignancies completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-29Clinical Trial Update: A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants [Phase 1, Phase 2]
Phase 1/2 study of idasanutlin in combination with obinutuzumab for relapsed/refractory follicular lymphoma and with rituximab for relapsed/…
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202) [Phase 2]
Results from a Phase 2 study (CITADEL-202) of INCB050465 in relapsed or refractory diffuse large B-cell lymphoma have been completed and pos…
-
CLINICAL_TRIALS trial_result · 2020-04-22Clinical Trial Update: PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine) [Phase 2]
Phase 2 trial update for PNT2258 in relapsed/refractory diffuse large B-cell lymphoma (DLBCL) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-01Clinical Trial Update: Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma [Phase 2]
Phase 2 trial evaluating chidamide with VDDT regimen in relapsed/refractory diffuse large B-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2020-03-30Clinical Trial Update: Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma [Phase 3]
A Phase 3 trial comparing lenalidomide plus R-CHOP against placebo plus R-CHOP in untreated ABC-type diffuse large B-cell lymphoma has compl…
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Safety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma [Phase 2]
Phase 2 study of blinatumomab in adults with newly diagnosed high-risk diffuse large B-cell lymphoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating everolimus and lenalidomide in relapsed or refractory non-Hodgkin or Hodgkin lymphoma; results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-11Clinical Trial Update: Lenalidomide Plus ICE in the Treatment of Refractory and Relapsed DLBCL [Phase 2]
Phase 2 trial evaluating lenalidomide in combination with ICE for refractory/relapsed diffuse large B-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2020-03-11Clinical Trial Update: Decitabine Plus R-CHOP in Diffuse Large B-cell Lymphoma [Phase 1, Phase 2]
Clinical trial update for decitabine plus R-CHOP in diffuse large B-cell lymphoma (Phase 1/Phase 2) with unknown status.
-
CLINICAL_TRIALS trial_result · 2020-02-26Clinical Trial Update: TGR-1202 and Ibrutinib in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma [Phase 2]
Phase 2 trial evaluating TGR-1202 in combination with ibrutinib for relapsed or refractory diffuse large B-cell lymphoma has completed with …
-
CLINICAL_TRIALS trial_result · 2020-02-24Clinical Trial Update: Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma [Phase 1, Phase 2]
Phase 1/2 study evaluating lenalidomide plus rituximab in relapsed mantle cell lymphoma and diffuse large B-cell lymphoma; trial completed w…